148 related articles for article (PubMed ID: 25226534)
1. SP600125 induces Src and type I IGF receptor phosphorylation independent of JNK.
Kong Q; Hua H; Cui A; Shao T; Song P; Jiang Y
Int J Mol Sci; 2014 Sep; 15(9):16246-56. PubMed ID: 25226534
[TBL] [Abstract][Full Text] [Related]
2. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
3. Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor.
Liao WX; Feng L; Zheng J; Chen DB
Endocrinology; 2010 Jul; 151(7):3432-44. PubMed ID: 20463056
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation.
Lin CC; Lee IT; Hsu CH; Hsu CK; Chi PL; Hsiao LD; Yang CM
PLoS One; 2015; 10(3):e0118473. PubMed ID: 25734900
[TBL] [Abstract][Full Text] [Related]
5. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
6. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
7. Genistein inhibits cell growth by modulating various mitogen-activated protein kinases and AKT in cervical cancer cells.
Kim SH; Kim SH; Kim YB; Jeon YT; Lee SC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():495-500. PubMed ID: 19723095
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration.
Tsai HR; Yang LM; Tsai WJ; Chiou WF
Eur J Pharmacol; 2004 Sep; 498(1-3):45-52. PubMed ID: 15363974
[TBL] [Abstract][Full Text] [Related]
9. The cytoprotective effect of sulfuretin against tert-butyl hydroperoxide-induced hepatotoxicity through Nrf2/ARE and JNK/ERK MAPK-mediated heme oxygenase-1 expression.
Lee DS; Kim KS; Ko W; Li B; Jeong GS; Jang JH; Oh H; Kim YC
Int J Mol Sci; 2014 May; 15(5):8863-77. PubMed ID: 24857917
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
[TBL] [Abstract][Full Text] [Related]
11. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1.
Cho JE; Park S; Cho SN; Lee H; Kim YS
BMB Rep; 2012 Oct; 45(10):583-8. PubMed ID: 23101513
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways.
Kyotani Y; Zhao J; Tomita S; Nakayama H; Isosaki M; Uno M; Yoshizumi M
J Pharmacol Sci; 2010; 113(2):161-8. PubMed ID: 20508392
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2 and PKB phosphorylation.
Pandey NR; Vardatsikos G; Mehdi MZ; Srivastava AK
J Biol Inorg Chem; 2010 Mar; 15(3):399-407. PubMed ID: 19946718
[TBL] [Abstract][Full Text] [Related]
16. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.
Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE
PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537
[TBL] [Abstract][Full Text] [Related]
17. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
[TBL] [Abstract][Full Text] [Related]
18. The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.
Li M; Yin Y; Hua H; Sun X; Luo T; Wang J; Jiang Y
J Biol Chem; 2010 Oct; 285(40):30480-8. PubMed ID: 20670935
[TBL] [Abstract][Full Text] [Related]
19. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
Leahy M; Lyons A; Krause D; O'Connor R
J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
[TBL] [Abstract][Full Text] [Related]
20. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
Sayeed A; Lu H; Liu Q; Deming D; Duffy A; McCue P; Dicker AP; Davis RJ; Gabrilovich D; Rodeck U; Altieri DC; Languino LR
Oncotarget; 2016 Aug; 7(33):52618-52630. PubMed ID: 27438371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
